Continuing review of an approved and ongoing study posing more than minimal risk that was initially approved by a convened IRB:
Understand the Problem
The question concerns the continuing review process for an approved study that poses more than minimal risk, as initially approved by a convened Institutional Review Board (IRB). It asks to identify a true statement regarding this review process.
Answer
The continuing review must occur within 12 months of the approval date.
Must occur within 12 months of the approval date.
Answer for screen readers
Must occur within 12 months of the approval date.
More Information
For studies posing more than minimal risk, the IRB must conduct a continuing review at least once per year.
Tips
Read the question carefully and understanding the context of the question is very important.
Sources
AI-generated content may contain errors. Please verify critical information
Thank you for voting!
